Increasing reports of poor quality of medicines manufactured in India, whether as exports or for domestic consumption, are a matter of great concern. But this crisis should not become an excuse for strengthening corporate monopoly and excessive centralization. In this conversation, we discuss the why and how of designing a regulatory regime in India, that can guarantee quality medicines without any compromise to affordability or public health, not only for India, but for the entire third world.
Dr. Yogesh Jain
Last year, the ICMR initiated a process re-revisit WHO’s weight and height standards for children on grounds that these are not appropriate in the Indian context. But is this valid? Are current growth standards overstating India’s malnutrition crisis? In this conversation, Dr Yogesh Jain talks to Prof. Rakesh Lodha, AIIMS and Dr Pavitra Mohan,BHS, ( all of leading pediatric practitioners and academicians with experience in public policy) to clarify the issues and concerns underlying the current controversy and the values and goals that should inform our choice of standards.
This is a picture of a 18 month old girl with severe pain due to dactylitis. Needless suffering. !!. The current policy is aspirational but flawed and needs to get it’s priorities right …